Waldencast plc (NASDAQ:WALD – Get Free Report) was the recipient of a large increase in short interest in January. As of January 31st, there was short interest totalling 370,300 shares, an increase of 27.1% from the January 15th total of 291,400 shares. Approximately 1.1% of the company’s shares are short sold. Based on an average daily trading volume, of 95,300 shares, the days-to-cover ratio is presently 3.9 days.
Analyst Upgrades and Downgrades
WALD has been the topic of a number of recent research reports. Canaccord Genuity Group assumed coverage on Waldencast in a research report on Friday, October 25th. They issued a “buy” rating and a $5.00 price objective on the stock. TD Cowen started coverage on Waldencast in a research report on Monday, December 16th. They issued a “hold” rating and a $4.30 price objective for the company. Telsey Advisory Group restated an “outperform” rating and set a $6.00 target price on shares of Waldencast in a research report on Monday, November 18th. Canaccord Genuity Group lifted their price target on shares of Waldencast from $5.00 to $6.00 and gave the stock a “buy” rating in a research report on Friday, November 22nd. Finally, DA Davidson increased their price objective on shares of Waldencast from $7.25 to $7.50 and gave the company a “buy” rating in a report on Wednesday, December 4th. One investment analyst has rated the stock with a hold rating and four have issued a buy rating to the stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $5.76.
Check Out Our Latest Research Report on Waldencast
Institutional Inflows and Outflows
Waldencast Trading Down 4.1 %
WALD traded down $0.13 during midday trading on Friday, reaching $3.07. 48,218 shares of the company were exchanged, compared to its average volume of 78,013. Waldencast has a one year low of $2.40 and a one year high of $8.35. The stock’s 50-day simple moving average is $3.48 and its 200 day simple moving average is $3.42. The company has a debt-to-equity ratio of 0.21, a current ratio of 1.47 and a quick ratio of 0.78.
Waldencast Company Profile
Waldencast plc operates in the beauty and wellness business. The company engages in developing, acquiring, accelerating, and scaling various brands. It provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians.
Further Reading
- Five stocks we like better than Waldencast
- 3 Ways To Invest In Coffee, Other Than Drinking It
- Roblox’s Big Dip: A Chance to Get in on the Vaunted Gaming Stock?
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- 3 Dividend ETFs to Capitalize on the Slide in Chip Stocks
- Are Penny Stocks a Good Fit for Your Portfolio?
- Is Chevron Stock Primed for Growth After Profit-Boosting News?
Receive News & Ratings for Waldencast Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waldencast and related companies with MarketBeat.com's FREE daily email newsletter.